Subscribe Now Subscribe Today
Science Alert Home Journals at Science Alert For Authors For Subscribers Contact Us
 
FOLLOW US:     Facebook    Twitter
   
 
    Publisher: Academic Journals Inc., USA
   
  International Journal of Cancer Research dedicated to publish significant, original studies in all areas of basic, clinical, translational epidemiological and prevention research devoted to the study of cancer and cancer-related biomedical sciences. Scope of the journal covers: Cell and tumor biology, endocrinology, epidemiology, experimental therapeutics, molecular targets and chemical biology, immunology, molecular biology, patho-biology and genetics, prevention, pharmacology and physiology.

Submit your best paper to this journal via online submission system.
  Editor-in-Chief:  Hassan Tawhid Hassan
 
 
Bae, J.S., S.H. Park, K.M. Kim, K.S. Kwon and C.Y. Kim et al., 2015. CK2α phosphorylates DBC1 and involves in the progression of gastric carcinoma and predicts poor survival of gastric carcinoma patients. Int. J. Cancer, 136: 797-809.
PubMed  |  
Chung, Y.M., S.H. Park, W.B. Tsai, S.Y. Wang and M.A. Ikeda et al., 2012. FOXO3 signaling links ATM to the p53 apoptotic pathway following DNA damage. Nature Commun., Vol. 3. 10.1038/ncomms200.
CrossRef  |  PubMed  |  
Kang, K.Y., J.H. Park, I.H. Lim, S.G. Kim and S.H. Park et al., 2006. Crystallization of antiangiogenic kringle V derived from human apolipoprotein A: Crystallization applied to purification and formulation. Biosci. Biotechnol. Biochem., 70: 916-925.
PubMed  |  
Kang, S.H., S.H. Park, H.S. Shim and K.H. Lee, 2003. Non-phosphopeptide inhibitor for Lck SH2 domain: Solid-phase synthesis and structure activity relationship of rosmarinic acid analogs. Bull. Korean Chem. Soc., 24: 664-666.
Lee, K.H. and S.H. Park, 2004. The relationship between the pY+3 amino acid in the phosphopeptide ligands and the binding affinity for various SH2 domains. Protein Peptide Lett., 11: 527-532.
PubMed  |  
Liu, J.Y., S.H. Park, C. Morisseau, S.H. Hwang, B.D. Hammock and R.H. Weiss, 2009. Sorafenib has soluble epoxide hydrolase inhibitory activity which contributes to its effect profile in vivo. Mol. Cancer Therap., 8: 2193-2203.
CrossRef  |  PubMed  |  
Liu, R., H.I. Wettersten, S.H. Park and R.H. Weiss, 2013. Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer. Future Med. Chem., 5: 991-994.
PubMed  |  
Park, J.Y., S.H. Park and R.H. Weiss, 2009. Disparate effects of roscovitine on renal tubular epithelial cell apoptosis and senescence: Implications for ADPKD. Am. J. Nephrol., 29: 509-515.
PubMed  |  
Park, S.H., H.S. Oh, M.A. Kang, H. Cho, J.B. Prasad, J. Won and K.H. Lee, 2007. Structure activity relationship of the series of non-peptide small antagonists for p56lck sh2 domain. Bioorg. Med. Chem., 15: 3938-3950.
PubMed  |  
Park, S.H., J. Won and K.H. Lee, 2002. Design and characterization of non-phosphopeptide inhibitors for src family SH2 domains. Bioorg. Med. Chem. Lett., 12: 2711-2714.
PubMed  |  
Park, S.H., J.H. Lee, J.S. Berek and M.C.T. Hu, 2014. Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53. Int. J. Oncol., 45: 1691-1698.
PubMed  |  
Park, S.H., J.Y. Park and R.H. Weiss, 2008. Antisense attenuation of p21 sensitizes kidney cancer to apoptosis in response to conventional DNA-damaging chemotherapy associated with enhancement of phospho-p53. J. Urol., 180: 352-360.
PubMed  |  
Park, S.H., M.A. Kang, H.S. Shim, H. Cho, J. Won and K.H. Lee, 2006. Development of novel small chemical inhibitors for Lck SH2 domain with in vitro T-cell inhibitory activity. Bull. Korean Chem. Soc., 27: 1353-1358.
Park, S.H., S.H. Kang, S.H. Lim, H.S. Oh and K.H. Lee, 2003. Design and synthesis of small chemical inhibitors containing different scaffolds for lck SH2 domain. Bioorg. Med. Chem. Lett., 13: 3455-3459.
Direct Link  |  
Park, S.H., S.W. Yun, J.M. Park, S.H. Ok, J.H. Yu and D.H. Bai , 2000. Studies on xanthine oxidase inhibitor produced from Aspergilus SP. F184. Korean J. Microbiol. Biotechnol., 28: 92-96.
Park, S.H., X. Wang, R. Liu, K.S. Lam and R.H. Weiss, 2008. High throughput combinatorial screening of small molecules to identify attenuator of p21 as potential novel therapy of renal cell carcinoma. Cancer Biol. Ther., 7: 2015-2022.
PubMed  |  
Tsai, W.B., Y.M. Chung, Y. Zou, S.H. Park and Z. Xu et al., 2010. Inhibition of FOXO3 tumor suppressor function by beta-TrCP1 through ubiquitin-mediated degradation in a tumor mouse model. PLoS One, Vol. 5. .
Direct Link  |  
Won, J., Y.G. Hur, E.M. Hur, S.H. Park and M.A. Kang et al., 2003. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner. Eur. J. Immunol., 33: 870-879.
CrossRef  |  Direct Link  |  
Woo, S.H., S.H. Park, H.K. Lim and K.H. Jung, 2005. Extended operation of a pressurized 75-L bioreactor for shLkn-1 production by Pichia pastoris using dissolved oxygen profile control. J. Microbiol. Biotechnol., 32: 478-480.
PubMed  |  
Yao, N., W. Xiao, X. Wang, J. Marik, S.H. Park, Y. Takada and K.S. Lam, 2009. Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method. J. Med. Chem., 52: 126-133.
PubMed  |  

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 

                 home       |       journals        |       for authors       |       for subscribers       |       asci
          © Science Alert. All Rights Reserved